neoplasm
• heterozygotes develop an abrupt onset, rapidly fatal acute leukemia with a median age of overt onset of 10 months and penetrance of over 90%
(J:84230)
• heterozygotes develop acute promyelocytic leukemia with a 150-200 day latency and full penetrance by 350 days of age
(J:86458)
|
hematopoietic system
• progressive splenomegaly is seen prior to the onset of leukemia
|
• increased numbers of myeloblasts and promyelocytes are seen in mutants with leukemia
(J:84230)
• splenic myeloid expansion and aberrant CD34 Gr-1 double positive cells are seen in all mutants
(J:86458)
|
• extramedullary hematopoiesis is seen prior to the onset of leukemia
|
• seen in mutants with leukemia
|
• pronounced leukocytosis is seen in mutants with leukemia
|
immune system
• progressive splenomegaly is seen prior to the onset of leukemia
|
• increased numbers of myeloblasts and promyelocytes are seen in mutants with leukemia
(J:84230)
• splenic myeloid expansion and aberrant CD34 Gr-1 double positive cells are seen in all mutants
(J:86458)
|
• pronounced leukocytosis is seen in mutants with leukemia
|
liver/biliary system
• hepatomegaly with leukemic cell infiltrates is seen in mutants with leukemia
|
growth/size/body
• hepatomegaly with leukemic cell infiltrates is seen in mutants with leukemia
|
• progressive splenomegaly is seen prior to the onset of leukemia
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute myeloid leukemia | DOID:9119 |
OMIM:601626 |
J:84230 , J:86458 |